PATENT CLAIM ANALYSIS

Application Number: 15762852
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "252030"]

Abstract:
Described are compounds, which are antagonists of the P2Y 14  receptor, for example, a compound of formula (I) in which ring A, R 1 , R 2 , R 3 , and n are as described herein. Also provided are dendron conjugates comprising the compounds, and methods of using the compounds, including a method of treating a disorder, such as inflammation, diabetes, insulin resistance, hyperglycemia, a lipid disorder, obesity, a condition associated with metabolic syndrome, and asthma, and a method of antagonizing P2 14  receptor activity in a cell.

Claim (Index 2):
The compound of  claim 1 , wherein in formula (I), ring A is phenyl, furanyl, thiazolyl, thienyl, pyrazolyl, pyridazinyl, pyridinyl, pyrazinyl, benzofuranyl, cyclopropyl, or cyclohexyl, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 51.0
- Percentile: 90.0
- Lexical Diversity: 1.77049
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14352096', '15554829', '10015532', '15124654', '14305643']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7576386662687922
- 35 USC 102 Novelty (BERT): 0.5167641144153854
- Combined Prediction Score: 0.7335512110834516
- Mean Citation Score: 264.953122
- Max Citation Score: 268.13614
- Similarity Product: 184.2297073822856

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test